Compounds > cyclosporine

cyclosporine and Bile Duct Diseases

cyclosporine has been researched along with Bile Duct Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellini, MI; Cillis, A; Corona, L; Fratoni, S; Manzia, TM; Orlando, G; Tisone, G; Toti, L	1
Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O	1
Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM	1
Barksdale, EM; Donahoe, PK; Kleinman, RE; Maganaro, TF; Schreiber, RA	1

Other Studies

4 other study(ies) available for cyclosporine and Bile Duct Diseases

Article	Year
Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. Transplant international : official journal of the European Society for Organ Transplantation, 2011, Volume: 24, Issue:8 Topics: Bile Duct Diseases; Biopsy; Constriction, Pathologic; Cyclosporine; Humans; Liver; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Sarcoidosis; Sarcoidosis, Pulmonary; Sirolimus; Time Factors; Treatment Outcome	2011
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid. Liver, 2002, Volume: 22, Issue:6 Topics: Acute Disease; Adult; Bile Duct Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Hepatitis; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid	2002
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid. British journal of haematology, 1997, Volume: 96, Issue:4 Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid	1997
Rejection of murine congenic bile ducts: a model for immune-mediated bile duct disease. Gastroenterology, 1992, Volume: 102, Issue:3 Topics: Animals; Bile Duct Diseases; Bile Ducts; Cyclosporine; Disease Models, Animal; Fetal Tissue Transplantation; Graft Rejection; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Mice; Mice, Inbred C57BL	1992